On Thursday, Shares of Johnson & Johnson (NYSE:JNJ), lost -1.02% to $102.72.
Johnson & Johnson (JNJ) will take part in the 34th Annual JP Morgan Health Care Conference on Monday, Jan. 11, at the Westin St. Francis in San Francisco. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer, will represent the Company in a session planned at 2:30 p.m. (Pacific Time)/5:30 p.m. (Eastern Time).
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Shares of CONSOL Energy Inc. (NYSE:CNX), inclined 1.54% to $7.90, during its last trading session.
On Tuesday, December 29, 2015, Nasdaq Composite ended at 5,107.94, up 1.33%, Dow Jones Industrial Average advanced 1.10% to finish the day at 17,720.98, and the S&P 500 closed at 2,078.36, up 1.06%.
CONSOL Energy Inc.’s stock added 4.70% to close Tuesday’s session at USD 8.24. The company’s shares oscillated between USD 8.05 and USD 8.30. The stock recorded a trading volume of 5.74 million shares, which was below its 50-day daily average volume of 10.74 million shares and its 52-week average volume of 6.13 million shares. Over the last five days CONSOL Energy Inc.’s shares have advanced 3.39% and in the past one month the stock has gained a momentum of 3.00%. However, over the last three months the stock has lost 12.43% and year to date the shares have shed 75.20%. The company has returned 10.16% in the past one month, on a compounded total return basis. CONSOL Energy Inc. has a current dividend yield of 0.46%. The stock is trading at a price to book ratio of 0.38, which compares to a historical PB ratio near to 1.46. Additionally, the stock is trading at a price to cash flow ratio of 3.34 and a price to sales ratio of 0.62.
CONSOL Energy Inc., together with its auxiliaries, operates as an integrated energy company in the United States and internationally. The company operates through two divisions, Exploration and Production (E&P), and Coal. The E&P division produces pipeline quality natural gas primarily to gas wholesalers.
Finally, Amedica Corporation (NASDAQ:AMDA), ended its last trade with 8.00% gain, and closed at $0.119.
Amedica Corporation (AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, declared the execution of a private label supply agreement with BoTEC Medical, a partner of WinnTi Medical Group and one of the fastest growing orthopedic companies in the People’s Republic of China focused on extremity and spine solutions. This agreement marks the establishment of a long-term collaborative partnership between the two companies.
Following the terms of the non-exclusive private label agreement, Amedica will supply BoTEC Medical with proprietary silicon nitride spinal interbody fusion devices for distribution and sale in their worldwide markets.
“This planned alliance further validates the market adoption of our medical-grade silicon nitride technology platform internationally,” said Dr. Sonny Bal, Chairman and Chief Executive Officer. “Since launching our second generation silicon nitride interbody fusion devices in 2014, we have been pursuing a multi-channel approach to provide broader accessibility to our proprietary silicon nitride biomaterial. We are very happy to partner with BoTEC Medical’s team and look forward to participating in their exciting future as they continue to capture additional market share within and outside one of the fastest growing medical device markets in the world.”
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America.